CapsoVisionCV -0.95%10 14-Day RSI is 54.37 as of Jul. 04, 2026. GuruFocus rates CV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 870 Medical Devices & Instruments companies, CapsoVision ranks worse than 70.11% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-04), CapsoVision's 14-Day RSI is 54.37.
The industry rank for CapsoVision's 14-Day RSI or its related term are showing as below:
CV's 14-Day RSI is ranked worse than 70.11% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: 47.555
vs CV: 54.37
CapsoVision (NAS:CV) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
CapsoVision 14-Day RSI Related Terms
CV vs OFIX, CATX, ELMD: 14-Day RSI Comparison
For the Medical Devices subindustry, CapsoVision's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CapsoVision 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CapsoVision's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where CapsoVision's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CapsoVision (CV) has a 14-Day RSI of 54.37 as of Jul. 04, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on CapsoVision and its competitors. According to the industry distribution chart, CapsoVision ranks #610 out of 870 companies in the Medical Devices & Instruments industry, placing it in the top 70.1%.
Is CapsoVision's 14-Day RSI too high?
CapsoVision's current 14-Day RSI is 54.37. The Medical Devices & Instruments industry median 14-Day RSI is 47.56. CapsoVision's value of 54.37 is 14.3% above this industry median. Based on the distribution chart, CapsoVision ranks #610 out of 870 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CapsoVision has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CapsoVision's 14-Day RSI compare to OFIX and CATX?
According to the Medical Devices & Instruments industry distribution chart, CapsoVision ranks #610 out of 870 companies for 14-Day RSI. This places CapsoVision in the lower half of its industry. The industry median 14-Day RSI is 47.56. CapsoVision's value of 54.37 is 14.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 47.56, based on 870 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CapsoVision's current 14-Day RSI of 54.37 is 14.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on CapsoVision and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 47.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CapsoVision's current 14-Day RSI is 54.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CapsoVision stock overvalued right now?
CapsoVision (CV) has a current 14-Day RSI of 54.37. The current 14-Day RSI is 54.37 and 14.3% above the Medical Devices & Instruments industry median of 47.56. CapsoVision's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For CapsoVision (CV), the current 14-Day RSI is 54.37 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
10GF Score
Get the complete analysis for CV
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CV has been successfully added to your 